Gene Query: ADAM23

Dataset Description Geneva Score
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 71.1
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 52.7
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 52.05
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 51.8
Statins modulate endothelial transcriptional profile by inhibiting EZH2 49.41
RNA-seq of human fibroblasts after irradiation 48.27
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 47.74
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 47.74
RNA-sequencing of formalin fixed human primary melanoma tissue 47.52
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 39.76
CD86 regulates a pro-survival signal in myeloma cells 39.45
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 39.37
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 39.37
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 38.58
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 38.35
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 37.2
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 36.34
RNA-seq analysis of uveal melanoma cells treated with FR900359 36.08
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 35.26
RNA-seq of young and quiescent MRC-5 human fibroblasts 35.19
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 33.33
RNA expression following TMPRSS11B overexpression or depletion 30.48
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 29.13
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 28.45
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 28.0
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 27.03
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 25.36
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 24.57
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 24.55
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 23.88
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 23.27
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 22.7
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 22.7
Gene expression profile of multiple myeloma cell lines treated with CB-5083 22.36
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 20.64
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 20.64
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 20.54
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 19.95
Epigenetic reprogramming of melanoma cells by vitamin C treatment 19.89
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 19.79
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 19.49
Effect of mitochondria deficiency on senescence-associated gene expression 19.33
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 19.16
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 19.16
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 19.07
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 18.86
Differential gene expression of human melanoma cells [RNA-seq] 18.41
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 18.41
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 17.95
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 17.15
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 17.15
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 15.28
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 15.28
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 15.19
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 15.19
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 14.66
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 14.51
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 14.2
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 14.19
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 14.04
Mutational landscape of splicing genes and functional consequences across 33 cancer types 14.0
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 13.88
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 13.86
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 13.8
SF3B1 Degron knockdown RNA-seq 13.25
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 13.22
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 13.13
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 12.94
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 12.92
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 12.78
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 12.74
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 12.58
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 12.52
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 12.45
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 12.1
Investigation about fibroblasts of different origins in culture 11.96
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 11.94
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 11.81
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 11.81
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 11.72
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 11.58
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 11.55
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 11.53
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 11.52
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 11.33
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 11.15
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 11.14
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 11.13
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 10.97
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 10.97
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 10.95
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 10.68
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.64
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 10.6
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 10.6
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 10.3
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 10.24
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 10.23
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 10.06
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 10.04
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 10.04
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 9.98
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 9.88
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 9.73
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 9.52
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 9.52
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 9.5
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 9.46
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 9.36
Effect of from Human Umbilical Vein Endothelial Cells 9.34
Maturation of human iNSCs 9.18
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.09
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 9.01
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 8.96
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 8.89
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 8.83
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 8.79
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 8.75
Dynamic reorganization of nuclear architecture during human cardiogenesis 8.73
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 8.73
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 8.68
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 8.65
Modeling Familial Cancer with iPSC Approaches 8.58
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 8.55
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 8.45
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 8.42
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 8.38
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 8.28
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 8.25
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 8.15
Transcriptional effect of ETV1 knockdown in melanoma cells 8.11
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.06
Regionally specified human pluripotent stem cell-derived astrocytes 7.87
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 7.81
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 7.68
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 7.68
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 7.68
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 7.24
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.13
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 7.09
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 7.02
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 7.02
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 6.99
Gene expression changes in human melanoma cell lines compared to primary melanocytes 6.97
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 6.9
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 6.89
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.89
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 6.89
The evolution of N6-methyladenosine in primates 6.87
Integrin signaling regulates YAP/TAZ to control skin homeostasis 6.7
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 6.7
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.66
BMS-470539 on human synovial fibroblasts 6.58
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 6.56
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.52
RNA-seq of human aneuploid cell lines with Trisomy 21 6.49
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.43
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 6.4
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 6.3
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.29
RNA-seq analysis upon ARID1B overexpression 6.26
Effect of disulfiram treatment on pediatric high grade glioma 6.22
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.2
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 6.17
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 6.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 6.16
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 6.04
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 5.97
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 5.95
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 5.88
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 5.88
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 5.86
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 5.85
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 5.78
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.78
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 5.77
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 5.77
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 5.77
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 5.7
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 5.7
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 5.68
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.65
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 5.63
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 5.63
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 5.62
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 5.61
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.55
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.55
Fbxo32 mediated gene expression program underlies EMT and metastasis 5.51
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 5.47
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 5.38
CHCHD2 gene KO effect in iPSC drived motor neurons 5.34
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 5.27
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.26
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 5.23
Tumor exosome integrins determine organotropic metastasis 5.22
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 5.19
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.16
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.16
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 5.13
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 5.12
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 5.03
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 4.96
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.96
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.94
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.91
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.91
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 4.84
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 4.82
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 4.82
Gene expression regulated by CSA and CSB in neuroblastoma cell line 4.81
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.8
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.8
Tyrosine Kinase Inhibitor Cardiotoxicity 4.8
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 4.8
RNAseq in Alzheimer's Disease patients 4.77
circRNA-sequencing 4.76
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.74
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.73
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.72
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 4.66
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 4.64
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 4.64
Examining serotonergic neuron differentiation from human iPSCs 4.63
Seletive inhibition of CDK9 in DLBCL cell lines 4.62
BI Human Reference Epigenome Mapping Project 4.61
O-glcnAc reprograms cellular energetics 4.61
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 4.61
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 4.6
Identification of Atrial Fibrillation associated genes and functional non-coding variants 4.59
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.56
The Glioma-Infiltrating T Cell Receptor Repertoire 4.55
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 4.52
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 4.5
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 4.5
An acquired vulnerability of drug resistant melanoma with therapeutic potential 4.5
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 4.5
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 4.44
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 4.43
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 4.42
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 4.42
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 4.36
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 4.36
RNA-Seq of the corpus callosum from 12 individuals 4.35
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.3
RNA-seq of cancer cell lines treated with T-025 4.28
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 4.27
The pause-initiation limit restricts transcription activation in human cells 4.25
FOXP1 orchestration of ASD-relevant signaling pathways. 4.2
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.2
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.2
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.16
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.14
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 4.12
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 4.12
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.11
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.11
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.09
Human embryonic stem cells in E8 and AKIT culture medium 4.09
RNA sequencing analysis of human embryonic stem cells and axial progenitors 4.07
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.07
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 4.06
Lineage specific differentiation is influenced by state of human pluripotency 4.04
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 4.04
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 4.04
Differentially expressed vascular development genes for iPSC-ECs from CDI 4.01
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 4.01
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 3.99
Cleavage Factor Im as a key regulator of 3’ UTR length 3.98
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.98
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.97
Gene expression profiling in metabolically heterogeneous human lung tumors 3.94
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 3.93
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 3.9
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 3.9
RNA Sequencing of Human iPS derived Cardiomyocytes 3.86
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 3.82
Gene expression changes after LOC550643 silencing 3.8
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 3.8
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.8
Transcriptional responses of melanoma cells to BRAF inhibition 3.79
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.78
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.77
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.77
Repurposing of promoters and enhancers during mammalian evolution 3.76
R430: A potent inbibitor of DNA and RNA viruses 3.72
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 3.7
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 3.7
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 3.64
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.64
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 3.62
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.56
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.56
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.55
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.54
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.54
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.54
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.54
Cell responses to dysregulated VZV-induced cell-cell fusion 3.52
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.52
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 3.52
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 3.51
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.49
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 3.49
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 3.49
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 3.42
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 3.39
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 3.38
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.37
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.37
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.36
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.34
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 3.3
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 3.3
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 3.27
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 3.27
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.27
RNA sequencing with KSHV infection and enrichment for circular RNAs 3.25
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.25
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.25
Random mono-allelic expression in MECP2-mutated cells 3.22
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 3.22
Gene expression patterns define the hepatocyte-like cells derived by different strategies 3.22
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.17
Molecular Mechanisms of Endothelial Hyperpermeability 3.15
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.12
Transcriptomes in healthy and CHB fetal hearts 3.07
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 3.0
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 2.99
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2.96
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.91
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.91
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 2.9
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 2.9
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 2.86
Gene profiling of human adult and pediatric liver cancer cells 2.86
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 2.83
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.78
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.75
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 2.74
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.73
Landscape and variation of RNA secondary structure across the human transcriptome 2.72
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 2.71
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 2.71
Transcriptome of human white and brown adipose tissue biopsies 2.69
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 2.67
iPSC-Derived Cholangiocytes 2.66
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 2.64
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.61
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.53
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.53
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 2.53
The age and genomic integrity of neurons after cortical stroke in humans 2.46
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.42
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 2.38
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.37
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.36
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 2.35
circRNA profile in hypopharyngeal cancer 2.33
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.33
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 2.33
AMPK signaling for naïve pluripotency 2.33
AMPK signaling for naïve pluripotency [Hs] 2.33
Gene expression in GBM with Cav3.2 inhibition 2.33
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.31
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.31
Epigenomic conservation of transposable element silencing [RNA-seq] 2.29
Epigenomic conservation of transposable element silencing 2.29
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.28
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 2.26
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 2.21
Identification of expressed and conserved human non-coding RNAs 2.21
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 2.19
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.17
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 2.1
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.08
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.07
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.06
RNA-seq in endometrial stromal tumors 2.03
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 1.96
RNA-sequencing of healthy human skeletal myocytes 1.94
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.92
Non-coding regions are the main source of tumor-specific antigens 1.92
Non-coding regions are the main source of tumor-specific antigens [human] 1.92
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.87
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.86
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.86
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 1.84
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.8
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.8
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.74
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.71
1.68
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.64
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.64
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.64
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.62
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.6
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.58
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.58
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 1.56
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 1.56
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.56
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.51
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.49
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 1.44
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.42
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.42
FOXP2's impact on the primate transcriptome 1.4
Human ovarian granulosa cell transcriptome 1.37
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.33
BET bromodomain inhibition 1.33
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.32
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 1.3
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 1.3
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.28
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.28
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.26
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 1.24
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.24
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.23
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.22
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.19
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.13
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.08
RNA-Seq in PWS iPSC-derived neurons 1.07
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.06
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.03
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.03
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.0
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 0.99
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 0.97
Downregulation of DDX5/DDX17 and REST 0.95
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.93
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.93
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.92
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.91
Bone marrow derived human B cells [normal proB] 0.91
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.88
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.82
ML29755 RNA-seq data 0.81
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 0.81
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.81
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.81
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.77
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.77
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.74
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.72
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.71
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.71
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.7
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.66
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.62
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.61
Co-regulation of splicing by Rbfox1 and hnRNP M 0.6
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.6
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.59
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.59
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.59
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.59
Noncoding regions are the main source of targetable tumor-specific antigens 0.58
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 0.58
Global transcriptome analysis of WT versus HEB-/- hESCs 0.55
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.55
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.54
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.54
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.52
The transcriptome of Kawasaki Disease arteritis 0.5
JAK dependent survival of ALK- ALCL 0.49
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.48
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.44
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.44
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 0.44
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.42
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.4
Dilated cardiomyopathy vs Myocarditis 0.39
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.37
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.37
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.35
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.34
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.34
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.33
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.33
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.31
Gene expression profile of CRC-derived HILEC 0.31
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.3
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.3
Hepatic transcriptome of pediatric hepatoblastoma. 0.28
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.27
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.27
Expression profiles of the four human major ectodermal lineages 0.26
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.25
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.24
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.22
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.19
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.16
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.16
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.13
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.02
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation